The whole world is grappling with the Covid-19 response, which by now is clearly a whole lot more than a short term crisis. There are still so many unknowns that are leading to a deluge of speculation about what could and should happen in all aspects of life moving forward, but there is already much real-time evidence within the health setting to serve as an anchor for our perspective and offer more practical guidance and inspiration.
Join us for what promises to be a fascinating insight into the current opinions of senior health leaders from the NHS, independent sector and life sciences organisations in the UK, followed by a panel discussion among three prominent figures working within the UK health economy, who will share their individual views on the journey so far, the progress they have already witnessed across their respective focus areas, and the opportunities and roadblocks across the sector moving forward.
The event will be chaired by CEO of ZPB Associates, Zoe Bedford, who will share the results of a wider piece of qualitative research undertaken during June-August amongst senior health leaders, and covers topics such as:-
- How the NHS is managing the Covid-19 response as it moves into the ‘third phase’
- Private: public sector collaboration – best practice and the appetite for more
- What’s top of the list of priorities and what’s taking a back seat
- The reality of progress towards a technology revolution in the health space
Zoe will then lead a panel discussion before opening up the session to audience Q&As, which will include views on the role communicators can play in making sure that this seismic event is managed optimally in the shorter term and leads to positive and sustainable change in the longer run.
Speakers include:
- Zoe Bedford - CEO of ZPB Associates
- Parker Moss - Chief Commercial and Partnership Officer at Genomics England
- Graham Kendall - Director of the Digital Healthcare Council
- Samuel Hollis - Business Unit Director - Cardio, Renal, Metabolic (CRM Franchise) and Respiratory (R&I Franchise), Novartis
Speaker Biographies
Parker Moss
Parker is Chief Commercial and Partnership Officer at Genomics England. He also sits on the Health Secretary’s Technology advisory board and Cancer Research UK’s Technology board. Previously, Parker was an entrepreneur in residence for healthcare technology at the F-Prime and Eight Road venture capital funds. This led him to the position of Chief Business Officer at Owkin; a start-up funded by F-Prime and Eight Roads that supports scientific research in cancer and severe disease with an AI-based platform. Previously, Parker spent five years working with the NHS, most recently as Chief Technology Officer of Virgin Care. He also led the digital strategy and roadmap for Great Ormond Street Hospital for Children.
Samuel Hollis
Samuel is Business Unit Director - Cardio, Renal, Metabolic (CRM Franchise) and Respiratory and Inflammation (R&I Franchise), and sits on the UK PEC (pharma executive committee) for Novartis. As a leading global medicines company, Novartis use innovative science and digital technologies to create transformative treatments in areas of great medical need, with a mission to reimagine medicine to improve and extend people’s lives. Prior to his time at Novartis Samuel spent 15 years at AstraZeneca, working in many different roles including sales, medical, marketing, global and spending time in the US and Switzerland as well as the UK.
Graham Kendall
Graham is Director of the Digital Healthcare Council, a membership organisation whose aim is to create a vibrant digital health ecosystem that works for patients. The DHC members deliver care digitally both directly to patients and by working in partnership with others, and the DHC represents their interests as a whole, working to inform the development of policy and regulation in the digital healthcare space. Graham has advised numerous organisations across healthcare including the Department of Health, NHS Trusts and independent sector providers as well as commercial and not-for-profit organisations. He also has over a decade of experience working in Parliament advising frontbenchers in Government and Opposition as well as working with backbench MPs from all parties, and serving as a local Councillor.
Zoe Bedford
Zoe is the CEO of ZPB Associates, a healthcare strategy, marketing and communications firm that works with organisations looking to grow in the health sector. ZPB’s purpose is to build an environment where the NHS, independent sector and life sciences can have better connected and productive partnerships. Zoe sits on the UK Board of the global business network the Entrepreneurs’ Organisation (EO), and is Trustee of the public health charity C3 Collaborating for Health, which works globally to improve lifestyle factors that drive the rise in non-communicable diseases. Prior to founding ZPB, Zoe was head of marketing and communications at Dr Foster, a health intelligence company, where she edited three editions of the influential Hospital Guide.